Platelet transfusion enhances pro-aggregatory status shortly after coronary artery bypass grafting (CABG while modulating platelet pro-inflammatory state 1-week post-surgery.
Post-Coronary Artery Bypass Grafting Outcomes of Patients with/without Type-2 Diabetes Mellitus and Chronic Kidney Disease Treated with SGLT2 Inhibitor Dapagliflozin: A Single-Center Experience Analysis.
Al Namat R, Duceac LD, Chelaru L, Dabija MG, Guțu C, Marcu C, Popa MV, Popa F, Bogdan Goroftei ER, Țarcă E.
Diagnostics (Basel). 2023 Dec 21;14(1):16. doi: 10.3390/diagnostics14010016.
Association of blood urea nitrogen to creatinine ratio and long-term outcome among women with coronary artery bypass grafting surgery: filling gaps in female.
Zhang K, Zhang R, Li B, Cui D.
BMC Nephrol. 2025 Aug 7;26(1):443. doi: 10.1186/s12882-025-04283-0.
Platelet transfusion enhances pro-aggregatory status shortly after coronary artery bypass grafting (CABG while modulating platelet pro-inflammatory state 1-week post-surgery.
Ahmadi J, Hosseini E, Kargar F, Maghsudlu M, Ghasemzadeh M.
J Cell Mol Med. 2024 Aug;28(15):e18573. doi: 10.1111/jcmm.18573.
Analysis of cardiac arrest after coronary artery bypass grafting.
Yang T, Tiemuerniyazi X, Hu Z, Feng W, Xu F.
J Cardiothorac Surg. 2024 Jul 16;19(1):451. doi: 10.1186/s13019-024-02963-w.
A comparative study examining the impact of coronary artery bypass grafting surgery with non-extracorporeal circulation on heart function and structure in patients with various forms of coronary heart diseases.
Bai XP, Li JX, Ma JL, Tian XB, Han C, Wang Y.
Medicine (Baltimore). 2024 Jul 19;103(29):e38844. doi: 10.1097/MD.0000000000038844.
Muscle strength trajectories and their association with postoperative health-related quality of life in patients undergoing coronary artery bypass grafting surgery: a prospective cohort study.
Hartog J, Dijkstra S, Dieperink W, Hoekstra T, Fleer J, van der Woude LHV, van der Harst P, Nijsten M, Mariani MA, Blokzijl F.
BMC Cardiovasc Disord. 2023 Jan 16;23(1):20. doi: 10.1186/s12872-023-03056-7.
Protective effect of dexmedetomidine in coronary artery bypass grafting surgery.
Ren J, Zhang H, Huang L, Liu Y, Liu F, Dong Z.
Exp Ther Med. 2013 Aug;6(2):497-502. doi: 10.3892/etm.2013.1183. Epub 2013 Jun 25.
Late-Onset Chylothorax After Coronary Artery Bypass Grafting.
Okiljević B, Nemet M, Zdravkovic R, Ergelašev S, Ergelašev I.
Cureus. 2023 Nov 15;15(11):e48843. doi: 10.7759/cureus.48843. eCollection 2023 Nov.
Cognitive outcomes following coronary artery bypass grafting: A systematic review and meta-analysis of 91,829 patients.
Greaves D, Psaltis PJ, Ross TJ, Davis D, Smith AE, Boord MS, Keage HAD.
Int J Cardiol. 2019 Aug 15;289:43-49. doi: 10.1016/j.ijcard.2019.04.065. Epub 2019 Apr 24.
Effects of on-pump versus off-pump coronary artery bypass grafting on myocardial metabolism.
Xie HT, Kang XQ, Zhang S, Tian YC, Liu DJ, Bai BJ.
Medicine (Baltimore). 2019 Apr;98(17):e15351. doi: 10.1097/MD.0000000000015351.
